New genetic testing in prenatal diagnosis

Seminars in Fetal and Neonatal Medicine

Volumn 19, Issue 3, 2014, Pages 214-219

  Babkina, Natalia ^a   Graham, John M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromosomal microarray; Exome sequencing; Next generation sequencing; Non invasive prenatal screening; Preimplantation genetic testing

Indexed keywords

BIOINFORMATICS; CHROMOSOMAL MICROARRAY; CHROMOSOME MOSAICISM; CHROMOSOME REARRANGEMENT; CLONING; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL MALFORMATION; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DIAGNOSTIC TEST; EXOME; EXOME SEQUENCING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; HAPLOTYPE; HUMAN; KARYOTYPE; LABORATORY DIAGNOSIS; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REVIEW; SEQUENCE ANALYSIS; SEX CHROMOSOME ABERRATION; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; COUNSELING; FEMALE; MATERNAL AGE; PREGNANCY; PROCEDURES;

COUNSELING; FEMALE; GENETIC TESTING; HUMANS; MATERNAL AGE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84901602597     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.10.005     Document Type: Review

References (50)

1. Steele M.W., Breg W.R. Chromosome analysis of human amniotic fluid cells. Lancet 1966, 1:383-385.
2. Lo Y.M.D., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
3. Yoon P., Scheuner M. The family history public health initiative. Centers for Disease Control and Prevention. Genomics and population health: United States 2003 2004, 39-45. CDC, Atlanta.
4. Frezzo T.M., Rubinstein W.S., Dunham D., Ormond K.E. The genetic family history as a risk assessment tool in internal medicine. Genet Med 2003, 5:84-91.
5. Schluth-Bolard C., Labalme A., Cordier M.P. Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations. J Med Genet 2013, 50:144-150.
6. Brent R.L. Environmental causes of human malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 2004, 113:957-968.
7. Moeschler J.B., Shevell M. American Academy of Pediatrics Committee on Genetics: clinical genetics evaluation of the child with mental retardation or developmental delay. Pediatrics 2006, 117:2304-2316.
8. Schoumans J., Ruivenkamp C., Holmberg E., Kyllerman M., Anderlid B.M., Nordenskjold M. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridization (array-CGH). J Med Genet 2005, 42:699-705.
9. Poot M., Hochstenbach R. A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 2010, 12:478-485.
10. Crow J.F. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 2000, 1:40-47.
11. Glaser R.L., Jabs E.W. Dear old dad. Sci Aging Knowledge Environ 2004, (3). re1.
12. Friedman J.M. Genetic disease in the offspring of older fathers. Obstet Gynecol 1981, 57:745-749.
13. Kong A., Frigge M.L., Masson G., Besenbacher S., Sulem P., Magnusson G., et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488(7412):471-475.
14. Jung A., Schuppe H.C., Schill W.B. Are children of older fathers at risk for genetic disorders?. Andrologia 2003, 35:191-199.
15. Goriely A., McVean G.A., Röjmyr M., Ingemarsson B., Wilkie A.O. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003, 301(5633):643-646.
16. Byrne M., Agerbo E., Ewald H., Eaton W.W., Mortensen P.B. Parental age and risk of schizophrenia: a case-control study. Arch Gen Psychiatry 2003, 60:673-678.
17. Cantor R.M., Yoon J.L., Furr J., Lajonchere C.M. Paternal age and autism are associated in a family-based sample. Mol Psychiatry 2007, 12:419-421.
18. Shi Q., Martin R.H. Aneuploidy in human sperm: a review of the frequency and distribution of aneuploidy, effects of donor age and lifestyle factors. Cytogenet Cell Genet 2000, 90:219-226.
19. Handyside A., Kontogianni E.H., Hardy K., Winston R.M. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990, 344:768-770.
20. Wilton L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat Diagn 2002, 22:512-518.
21. Mastenbroek S., Twisk M., van der Veen F., Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011, 17:454-466.
22. Forman E.J., Tao X., Ferry K.M., Taylor D., Treff N.R., Scott R.T. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012, 27:1217-1222.
23. Verlinsky Y., Rechitsky S., Evsikov S., White M., Cieslak J., Lifchez A., et al. Preconception and preimplantation diagnosis for cystic fibrosis. Prenat Diagn 1992, 12:103-110.
24. Van Rij M.C., De Rademaeker M., Moutou C., Dreesen J.C., De Rycke M., Liebaers I., et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet 2012, 20:368-375.
25. Rechitsky S., Verlinsky O., Amet T., Rechitsky M., Kouliev T., Strom C. Reliability of preimplantation diagnosis for single gene disorders. Mol Cell Endocrinol 2001, 183:S65-S68.
26. Ethics Committee of the American Society for Reproductive Medicine Use of preimplantation genetic diagnosis for serious adult onset conditions: a committee opinion. Fertil Steril 2013, 100:54-57.
27. Harton G.L., Magli M.C., Lundin K., Montag M., Lemmen J., Harper J.C. European Society of Human Reproduction and Embryology (ESHRE) PGD Consortium/Embryology Special Interest Group-best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 2011, 26:41-46.
28. Rickman L., Fiegler H., Shaw-Smith C., Nash R., Cirigliano V., Voglino G., et al. Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J Med Genet 2006, 43:353-361.
29. Van den Veyver I.B., Patel A., Shaw C.A., Pursley A.N., Kang S.H., Simovich M.J., et al. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 2009, 29:29-39.
30. Shaffer L.G., Coppinger J., Alliman S., Torchia B.A., Theisen A., Ballif B.C., et al. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn 2008, 28:789-795.
31. Faas B.H., van der Burgt I., Kooper A.J., Pfundt R., Hehir-Kwa J.Y., Smits A.P., et al. Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250 k SNP array analysis. J Med Genet 2010, 47:586-594.
32. Park S.J., Jung E.H., Ryu R.S., Kang H.W., Ko J.M., Kim H.J., et al. Clinical implementation of whole genome array CGH as a first-tier test in 5080 pre and postnatal cases. Mol Cytogenet 2011, 4:12.
33. Wapner R.J., Martin C.L., Levy B., Ballif B.C., Eng C.M., Zachary J.M., et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012, 367:2175-2184.
34. Feenstra I., Hanemaaijer N., Sikkema-Raddatz B., Yntema H., Dijkhuizen T., Lugtenberg D., et al. Balanced into array: genome-wide array analysis in 54 patients with an apparently balanced de novo chromosome rearrangement and a meta-analysis. Eur J Hum Genet 2011, 19:1152-1160.
35. D'Amours G., Kibar Z., Mathonnet G., Fetni R., Tihy F., Desilets V., et al. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet 2012, 81:128-141.
36. Lun F.M., Chiu R.W., Allen Chan K.C., Yeung Leung T., Kin Lau T., Lo Y.M.D. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008, 54:1664-1672.
37. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Neveux L.M., Ehrich M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13:913-920.
38. Finning K.M., Chitty L.S. Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2011, 13:69-75.
39. Simpson J.L. Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status. Fertil Steril 2013, 99:1124-1134.
40. Moise K.J., Boring N.H., O'Shaughnessy R., Simpson L.L., Wolfe H.M., Baxter J.K., et al. Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers. Prenat Diagn 2013, 33:95-101.
41. Gonzalez-Gonzalez M.C., Garcia-Hoyos M., Trujillo-Tiebas M.J., Bustamante Aragones A., Rodriguez de Alba M., Diego Alvarez D., et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet 2008, 25:477-481.
42. Lim J.H., Kim M.J., Kim S.Y., Kim H.O., Song M.J., Kim M.H., et al. Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma. J Assist Reprod Genet 2010, 28:167-172.
43. Amicucci P., Gennarelli M., Novelli G., Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2009, 46:301-302.
44. Papasavva T., van Ijcken W.F., Kockx C.E., Van den Hout M.C., Kountouris P., Kythreotis L., et al. Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia. Eur J Hum Genet 2013, 21:1403-1410.
45. Bustamante-Aragones A., Gallego-Merlo J., Trujillo-Tiebas M.J., de Alba M.R., Ugarte M., Ramos C. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J Cyst Fibros 2008, 7:505-510.
46. Bustamante-Aragones A., Pérez-Cerdá C., Pérez B., de Alba M.R., Ugarte M., Ramos C. Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia. Mol Genet Metab 2008, 95:101-103.
47. Chiu R.W., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., Lo Y.M. Non invasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002, 48:778-780.
48. Bustamante-Aragones A., Vallespin E., Rodriguez de Alba M., Trujillo-Tiebas M.J., Gonzalez-Gonzalez C., Diego-Alvarez D., et al. Early noninvasive prenatal detection of a fetal CRB1 mutation causing Leber congenital amaurosis. Mol Vis 2008, 14:1388-1394.
49. Fan C., Gu W., Wang J., Blumenfeld Y.J., El-Sayed Y.Y., Quake S.R., et al. Noninvasive prenatal measurement of the fetal genome. Nature 2012, 487(7407):320-324.
50. Talkowski M.E., Ordulu Z., Pillalamarri V., Benson C.B., Blumenthal I., Connolly S., et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 2012, 367:2226-2232.